ANI Pharmaceuticals | ANIP - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

ANI Pharmaceuticals

ANI Pharmaceuticals reported $69.08M in Gross Profit on Sales for its fiscal quarter ending in March of 2023.


Gross Profit On Sales Change
ANI Pharmaceuticals ANIP:US USD 69.08M 11.17M
Eli Lilly LLY:US USD 5.33B 420.4M
Endo International ENDP:US USD 347.82M 10.83M
Hikma Pharmaceutical HIK:LN USD 642M 19M
Knight Therapeutics Inc GUD:CN CAD 40.76M 3.87M
Nektar Therapeutics NKTR:US USD 14.53M 1.26M
Novartis NVS:US USD 9.38B 215M
Perrigo PRGO:US USD 413.8M 31.2M
Sun Pharmaceuticals SUNP:IN INR 86.8B 2.43B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 1.65B 454M